Cardea Bio and the Georgia Tech Research Institute enter DARPA agreement to develop airborne SARS-CoV-2 sensors
The Defense Advanced Research Projects Agency (DARPA) recently awarded the Georgia Tech Research Institute (GTRI) an agreement, as part of their SenSARS program, to develop a sensing platform to detect airborne SARS-CoV-2 particles. Cardea Bio… Read More »Cardea Bio and the Georgia Tech Research Institute enter DARPA agreement to develop airborne SARS-CoV-2 sensors





